Company intelligence / Profile preview

Congenica

Hinxton, England, United Kingdom

Ownership: Private
Employees: ~125
Development stage: Other

Overview

Congenica’s software platform enables clinical interpretation of genomic data at scale, supporting rapid diagnosis in rare diseases and oncology; used globally, validated by the 100,000 Genomes Project and NHS Genomic Medicine Service, with evidence showing increased diagnostic yield and reduced turnaround times for genome analysis.

Therapeutic areas: OncologyInfectious DiseasesRare Diseases
Modalities: Software platform
Industry: Molecular Diagnostics

Partnerships

Genomics EnglandUK NHS Genomic Medicine ServiceGenomenonDECIPHER/DDD ProjectHong Kong Genome ProgramInternational labs (US, Germany, China)

Beyond the preview

Go deeper on Congenica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Congenica.

Explore the full profile